Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aniruthan Renukanthan"'
Autor:
Reshma S. Baliga, Joshua P. Dignam, Amie J Moyes, Robert M. H. Grange, Aisah A. Aubdool, Cristina Perez-Ternero, Michael E. J. Preedy, Aniruthan Renukanthan, Vanessa Lowe, Adrian J. Hobbs
Publikováno v:
British Journal of Pharmacology. 179:2443-2459
cGMP underpins the bioactivity of NO and natriuretic peptides and is key to cardiovascular homeostasis. cGMP-driven responses are terminated primarily by PDEs, but cellular efflux via multidrug resistance proteins (MRPs) might contribute. Herein, the
Autor:
Leighton J Seal, Jane Evanson, Benjamin Turner, Richard Quinton, Aniruthan Renukanthan, Richard Green, Peter MacCallum, Andrew Davies, Márta Korbonits
Publikováno v:
Endocrine. 50:496-503
One of the challenging issues in patients with complex problems is that the various diseases and their treatment can influence each other and present unusual hurdles in management. We investigated one such complex case. A 34-year-old XY male presente
Publikováno v:
Endocrine Abstracts.
Autor:
Reshma S. Baliga, Aniruthan Renukanthan, Inmaculada C Villar, Robert M H Allen, Kristen J. Bubb, Amie J Moyes, Adrian J. Hobbs
Publikováno v:
BMC Pharmacology & Toxicology
Cellular levels of cyclic GMP (cGMP) are tightly controlled by synthetic and degradative mechanisms. Pharmacological manipulation of these processes (e.g. soluble guanylate cyclase stimulators and phosphodiesterase 5 inhibitors) augments cGMP-depende